Target Name: CARD16
NCBI ID: G114769
Review Report on CARD16 Target / Biomarker Content of Review Report on CARD16 Target / Biomarker
CARD16
Other Name(s): caspase recruitment domain family member 16 | Pseudo-IL1B-converting enzyme | Pseudo interleukin-1beta converting enzyme | Caspase recruitment domain-only protein 1 | Caspase-1 dominant-negative inhibitor pseudo-ICE | CARD-only protein 1 | pseudo interleukin-1beta converting enzyme | Caspase recruitment domain-containing protein 16 | Pseudo-ICE | PSEUDO-ICE | CARD16 variant 1 | Caspase recruitment domain family member 16, transcript variant 1 | CARD only domain-containing protein 1 | caspase-1 dominant-negative inhibitor pseudo-ICE | pseudo-IL1B-converting enzyme | caspase-1 inhibitor COP | Caspase recruitment domain protein 16 | COP | LLID-114769 | pseudo interleukin-1 beta converting enzyme | CARD only protein | CAR16_HUMAN | caspase recruitment domain-only protein 1 | Caspase-1 inhibitor COP | COP1 | Pseudo interleukin-1 beta converting enzyme

CARD16: Unlocking The Regulatory Functions of A Key Protein

CARD16, also known as caspase recruitment domain family member 16, is a protein that is expressed in various tissues and cells throughout the body. It is a key regulator of cell death and has been implicated in a number of diseases, including cancer, neurodegenerative diseases, and autoimmune disorders.

One of the key functions of CARD16 is its role in cell death, which is a critical process that helps remove damaged or dysfunctional cells from the body. When cells are no longer able to function properly, they can become cancerous, leading to the development of cancer. CARD16 is also involved in the regulation of cell survival, which is critical for the development and maintenance of tissues and organs.

In addition to its role in cell death and survival, CARD16 is also involved in the regulation of inflammation. It has been shown to play a key role in the recruitment of immune cells to sites of infection or injury, which is important for the immune response.

CARD16 is also involved in a number of signaling pathways that are important for cellular processes. It has been shown to play a role in the regulation of cell adhesion, which is critical for the development and maintenance of tissues and organs. It is also involved in the regulation of cell signaling pathways that are important for cell growth, angiogenesis, and cancer development.

Despite its involvement in a number of important cellular processes, CARD16 has not yet been identified as a drug target or biomarker. This is because the functions of CARD16 are complex and not fully understood. However, its role in cell death and survival, as well as its involvement in inflammation and signaling pathways, make it an attractive target for future research.

In conclusion, CARD16 is a protein that is involved in a number of important cellular processes that are critical for the development and maintenance of tissues and organs. While it has not yet been identified as a drug target or biomarker, its role in cell death and survival, as well as its involvement in inflammation and signaling pathways, make it an attractive target for future research.

Protein Name: Caspase Recruitment Domain Family Member 16

Functions: Caspase inhibitor. Acts as a regulator of procaspase-1/CASP1 activation implicated in the regulation of the proteolytic maturation of pro-interleukin-1 beta (IL1B) and its release during inflammation. Inhibits the release of IL1B in response to LPS in monocytes. Also induces NF-kappa-B activation during the pro-inflammatory cytokine response. Also able to inhibit CASP1-mediated neuronal cell death, TNF-alpha, hypoxia-, UV-, and staurosporine-mediated cell death but not ER stress-mediated cell death. Acts by preventing activation of caspases CASP1 and CASP4, possibly by preventing the interaction between CASP1 and RIPK2

The "CARD16 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about CARD16 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

CARD17P | CARD18 | CARD19 | CARD6 | CARD8 | CARD8-AS1 | CARD9 | Cardiac Troponin | CARF | CARHSP1 | CARM1 | CARMAL | CARMIL1 | CARMIL2 | CARMIL3 | CARMN | Carnitine O-Palmitoyltransferase (CPT) | Carnitine O-Palmitoyltransferase 1 (CPT-1) | Carnitine O-palmitoyltransferase 2 | CARNMT1 | CARNS1 | CARS1 | CARS1-AS1 | CARS2 | CARTPT | CASC11 | CASC15 | CASC16 | CASC17 | CASC18 | CASC19 | CASC2 | CASC20 | CASC21 | CASC22 | CASC3 | CASC6 | CASC8 | CASC9 | CASD1 | Casein Kinase | Casein kinase I | Casein Kinase I gamma | Casein kinase II (CKII) | CASK | CASKIN1 | CASKIN2 | CASKP1 | CASP1 | CASP10 | CASP12 | CASP14 | CASP16P | CASP1P2 | CASP2 | CASP3 | CASP4 | CASP4LP | CASP5 | CASP6 | CASP7 | CASP8 | CASP8AP2 | CASP9 | Caspase | CASQ1 | CASQ2 | CASR | CASS4 | CAST | CASTOR1 | CASTOR2 | CASTOR3P | CASZ1 | CAT | Cathepsin | CATIP | CATIP-AS1 | CATSPER1 | CATSPER2 | CATSPER2P1 | CATSPER3 | CATSPER4 | CATSPERB | CATSPERD | CATSPERE | CATSPERG | CATSPERZ | CAV1 | CAV2 | CAV3 | CAVIN1 | CAVIN2 | CAVIN3 | CAVIN4 | CBARP | CBFA2T2 | CBFA2T3 | CBFA2T3-ZNF651 corepressor complex | CBFB